Making an Exception: PCT Library Services & Individual Funding Requests Richard Wilson Knowledge...
-
Upload
anne-marshall -
Category
Documents
-
view
221 -
download
0
Transcript of Making an Exception: PCT Library Services & Individual Funding Requests Richard Wilson Knowledge...
Making an Making an Exception:Exception:PCT Library ServicesPCT Library Services& Individual Funding Requests& Individual Funding Requests
Richard WilsonRichard Wilson
Knowledge ServicesKnowledge Services
Derbyshire County PCTDerbyshire County PCT
Resource Based Resource Based DecisionsDecisions The NHS allocates finite resources on The NHS allocates finite resources on
the basis of clinical needthe basis of clinical need PCTs are locally accountablePCTs are locally accountable Given the full support of the Court of Given the full support of the Court of
Appeal in Appeal in R v. Cambridgeshire Health R v. Cambridgeshire Health Authority ex parte B [1995] 1 WLR 898Authority ex parte B [1995] 1 WLR 898
No duty of care owed by PCTs to No duty of care owed by PCTs to patientspatients
PCT ObjectivesPCT Objectives
Increase the healthy lifespan of Increase the healthy lifespan of your client populationyour client population
Reduce inequality in healthy Reduce inequality in healthy lifespan of your client populationlifespan of your client population
Break evenBreak even
What’s in a Name?What’s in a Name?
OATSOATS
Individual funding Individual funding requestsrequests
Exceptional casesExceptional cases
Non-contract treatmentsNon-contract treatments
Interventions not normally Interventions not normally fundedfunded
Why Have IFR Panels?Why Have IFR Panels?
To manage those episodes of care To manage those episodes of care that fall outside contracting that fall outside contracting arrangements with local providersarrangements with local providers
To address rare events which To address rare events which require a use of resources not require a use of resources not covered under existing covered under existing arrangementsarrangements
i.e.i.e.
When it isn’t covered by anything When it isn’t covered by anything else!else!
Types of RequestsTypes of Requests
Service developmentsService developments Experimental: let’s try it and see Experimental: let’s try it and see Patient initiated requests Patient initiated requests Tertiary care and beyondTertiary care and beyond Exceptional or individual casesExceptional or individual cases
ExceptionalityExceptionality
A rare or unusual eventA rare or unusual event Far beyond what is usual in Far beyond what is usual in
magnitude or degree magnitude or degree Exceptional likelihood of benefitExceptional likelihood of benefit Most cases that come before Most cases that come before
Panel are not in any way, shape Panel are not in any way, shape or form exceptionalor form exceptional
Not Exceptional!Not Exceptional!
Social factorsSocial factors Culpability: it wasn’t the Culpability: it wasn’t the
patient’s faultpatient’s fault Efficacy: it works for this Efficacy: it works for this
patientpatient Rule of Rescue: we’ve tried Rule of Rescue: we’ve tried
everything else! everything else!
Examples of RequestsExamples of Requests
Breast augmentation / Breast augmentation / reduction (not just for reduction (not just for women!)women!)
Implanted electrical Implanted electrical stimulation for MSstimulation for MS
Botox for jaw dystoniaBotox for jaw dystonia Bilateral cochlear Bilateral cochlear
implantsimplants Grass pollen allergen Grass pollen allergen
extract for extract for rhinoconjunctivitisrhinoconjunctivitis
Deep brain stimulation Deep brain stimulation for Parkinson’s diseasefor Parkinson’s disease
Stereotactic radiosurgery Stereotactic radiosurgery for cerebral metsfor cerebral mets
Sacral nerve stimulation Sacral nerve stimulation for urinary incontinencefor urinary incontinence
Aromatherapy for OCD Aromatherapy for OCD and anxiety disorderand anxiety disorder
Pulmonary vein ablation Pulmonary vein ablation for AFfor AF
PDT for central serous PDT for central serous chorioretinopathychorioretinopathy
MR ultrasound MR ultrasound embolisation of uterine embolisation of uterine fibroidsfibroids
Hair transplantation for Hair transplantation for female pattern baldnessfemale pattern baldness
Any high cost drug not Any high cost drug not yet in the system!yet in the system!
Numbers of RequestsNumbers of Requests
Derbyshire County PCT received Derbyshire County PCT received about 700 IFR applications last about 700 IFR applications last yearyear
About 60% were approvedAbout 60% were approved Annual spend > £3,000,000Annual spend > £3,000,000 Majority decided out of PanelMajority decided out of Panel
IFR ProcessIFR Process
Receive requestReceive request TriageTriage Evidence gatheringEvidence gathering Panel meetingPanel meeting Communicating decisionCommunicating decision AppealAppeal
TriageTriage
Is there a policy, existing Is there a policy, existing contract, prior approval process, contract, prior approval process, NICE guideline, etc?NICE guideline, etc?
Is it specialised services, e.g. Is it specialised services, e.g. EMSCG?EMSCG?
Is it more appropriate for another Is it more appropriate for another group – e.g. complex case panel, group – e.g. complex case panel, mental health panel, children’s mental health panel, children’s services?services?
Evidence GatheringEvidence Gathering
Searcher Searcher mustmust have full case have full case documentationdocumentation
Evidence sources:Evidence sources:– NICE, SMC, Wales, HTAs, CE/CKSNICE, SMC, Wales, HTAs, CE/CKS– TRIP, Cochrane, Medline, EmbaseTRIP, Cochrane, Medline, Embase– Google ScholarGoogle Scholar– NeLM, DTB, EMEA, MeReC, conferencesNeLM, DTB, EMEA, MeReC, conferences
Levels of evidenceLevels of evidence Presentation of resultsPresentation of results
Author, date and country
Patient group
Study type (level of evidence)
Outcomes Key results Study Weaknesses
Brookes et al1993Australia
272 fractures over 6.5 years, 124 isolated fractures, 93% from RTA's
Retrospective review
Accident details, fracture grade, cardiac sequelae
Isolated fracture minimal complications, arrythmias seen with age>65, IHD or digoxin
Possible missed fractures, retrospective design
Hills et al1993Australia
172 fractures over 6.5 years, 89% from RTA's
Prospective cohort study
Associated injuries
No clear association with intrathoracic injury. Slight increase in thoracic spine injury
Data collection uncertain, no uniform cardiac screen
Bu'Lock et al1994UK
63 patients with central chest trauma, 45 seat belt related
Prospective cohort study
ECG findings and cardiac enzymes, echocardiography
None of these needed treatment and no adverse effects seen. ECG and enzymes correlated poorly with these findings. 25% of isolated seat belt injuries had pericardial effusion
Small numbers, not all had fractures
Panel MeetingPanel Meeting
Composition of PanelComposition of Panel Decision making forms, backed Decision making forms, backed
by detailed minutesby detailed minutes Is the proposed treatment:Is the proposed treatment:
– Clinically effective?Clinically effective?– Cost-effective?Cost-effective?– Affordable?Affordable?
Clinical EffectivenessClinical Effectiveness
NICE guidanceNICE guidance Evidence searchEvidence search Additional information from Additional information from
requesting clinicianrequesting clinician Clinical knowledge of Panel Clinical knowledge of Panel
membersmembers Specialist clinical expertise within Specialist clinical expertise within
PCTPCT
Cost-EffectivenessCost-Effectiveness
NICE thresholds:NICE thresholds:– £30,000 per QALY gained for curative £30,000 per QALY gained for curative
interventionintervention– £20,000 per QALY gained for palliative £20,000 per QALY gained for palliative
interventionintervention Actual primary care spends (BMJ, 2007):Actual primary care spends (BMJ, 2007):
– £12,000 per QALY gained in circulatory £12,000 per QALY gained in circulatory diseasedisease
– £19,000 per QALY gained in cancer£19,000 per QALY gained in cancer
AffordabilityAffordability
Richards report (Nov 2008)Richards report (Nov 2008)– ““Many stakeholders believe that the value Many stakeholders believe that the value
society places on supporting people nearing society places on supporting people nearing the end of their life is not adequately reflected the end of their life is not adequately reflected when the cost-effectiveness of drugs is when the cost-effectiveness of drugs is appraised.”appraised.”
– ““Recommendation 5: The Department of Recommendation 5: The Department of Health should work with NICE to assess Health should work with NICE to assess urgently what urgently what affordableaffordable measures could be measures could be taken to make available drugs used near the taken to make available drugs used near the end of life that do not meet the end of life that do not meet the cost‑effectiveness criteria currently applied to cost‑effectiveness criteria currently applied to all drugs.”all drugs.”
AffordabilityAffordability
NICE end-of-life treatments advice (Jan NICE end-of-life treatments advice (Jan 2009)2009)– “…“…there will be circumstances in which it there will be circumstances in which it
may be appropriate to recommend the use may be appropriate to recommend the use of treatments with high reference case of treatments with high reference case incremental cost effectiveness ratios” incremental cost effectiveness ratios” IFIF
– Short life expectancy (<24 months) Short life expectancy (<24 months) ANDAND– Life extension (>3 months) Life extension (>3 months) ANDAND– Nothing of comparable effectiveness Nothing of comparable effectiveness
available from NHS available from NHS ANDAND– Small patient population (<7000 p.a.)Small patient population (<7000 p.a.)
i.e.i.e.
Your life really is worth more than Your life really is worth more than other people’sother people’s
……If you’re about to die from If you’re about to die from cancercancer
……But only if it’s a rare oneBut only if it’s a rare one
The Price of LifeThe Price of Life
BBC2 documentary (June 2009)BBC2 documentary (June 2009) NICE reverses its decision on Revlimid NICE reverses its decision on Revlimid
(lenalidomide) for multiple myeloma(lenalidomide) for multiple myeloma NICE estimates:NICE estimates:
– a non-recurrent cost of treating a backlog a non-recurrent cost of treating a backlog of patients of £221,000 per 100,000 of patients of £221,000 per 100,000 population in the first year, andpopulation in the first year, and
– a recurrent cost of £107,000 per 100,000 a recurrent cost of £107,000 per 100,000 population per yearpopulation per year
SunitinibSunitinib
Following appeal, NICE reverses its Following appeal, NICE reverses its decision on sunitinib (Mar 2009)decision on sunitinib (Mar 2009)
At an estimated cost per QALY At an estimated cost per QALY gained of (compared to IFN-alpha):gained of (compared to IFN-alpha):
£105,000£105,000 Patients already started on IFN-alpha Patients already started on IFN-alpha
may get sunitinib in 2may get sunitinib in 2ndnd line line
Rule of RescueRule of Rescue
Cookson et al (2008)Cookson et al (2008) In a humane society:In a humane society:
– Allow exceptional departures from a cost Allow exceptional departures from a cost effectiveness norm in clinical decisions effectiveness norm in clinical decisions about identified individualsabout identified individuals
– Do not exempt any one group of Do not exempt any one group of unidentified individuals from the rules of unidentified individuals from the rules of opportunity cost at the expense of all opportunity cost at the expense of all othersothers
NICE now incorporates the Rule of NICE now incorporates the Rule of Rescue in its decision makingRescue in its decision making
……But PCTs will pick up the bill But PCTs will pick up the bill
Be Afraid…Be Afraid…